New Treatment Options for Severe Hypoglycemia
In this medfyle
Expert commentary by Brian M. Frier, BSc, MD, FRCP, FRCP
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Acknowledgements
This is a highlights summary of an oral session given at the ENDO Online 2020 and presented by:
Cecilia C. Low Wang, MD, FACP
University of Colorado School of Medicine, Aurora, CO, USA
The content is produced by Infomedica, the official reporting partner of ENDO Online 2020. The summary text was drafted by Patrick Moore, PhD, and reviewed by Marco Gallo, MD, an independent external expert, and approved by Raghu Mirmira, MD, PhD, the scientific editor of the program.
The presenting authors of the original session had no part in the creation of this conference highlights summary.
In addition, an expert commentary on the topic has been provided by:
Brian M. Frier, BSc (Hons), MD, FRCP (Edin), FRCP (Glas)
Edinburgh, United Kingdom
About the Expert
Brian M. Frier, BSc (Hons), MD, FRCP (Edin), FRCP (Glas)
Edinburgh, United Kingdom
Formerly Prof Frier was a consultant physician in general (internal) medicine and diabetes at the Royal Infirmary of Edinburgh (1987-2012) and previously at the Western Infirmary and Gartnavel General Hospital, Glasgow (1982-1987). Professor Frier graduated in Medicine at the Unuiversity of Edinburgh and trained in Edinburgh, Dundee and New York, USA, where he was a Research Fellow in Diabetes and Metabolism at The New York Hospital and Cornell University.
Prof Frier was formerly Chair of the UK Government Scientific Advisory Committee on Diabetes Research in Scotland (2003-06) and Chair of the Honorary Advisory Panel on Driving and Diabetes to the Secretary of State for the Department for Transport (2001-12).
Research: Prof Frier's principal research interest is the pathophysiology of hypoglycaemia in humans with particular relevance to diabetes. Other research interests in diabetes include cognitive function, insulin therapy and driving. He has published extensively on hypoglycaemia, and has co-authored two major textbooks on hypoglycaemia and diabetes. He has mentored 20 postgraduate research fellows working on hypoglycaemia.
Research Groups: Member of MRC Centre for Cognitive Ageing and Epidemiology, Edinburgh
Prof Frier continues to collaborate with colleagues in the UK and abroad on hypoglycaemia research including the effects on cognitive function, and studies on symptomatology, morbidity and epidemiology.
References
1. Khunti K, Alsifri S, Aronson R, et al. Impact of Hypoglycaemia on Patient-Reported Outcomes From a Global, 24-country Study of 27,585 People With Type 1 and Insulin-Treated Type 2 Diabetes. Diabetes Res Clin Pract. 2017 Aug;130:121-129.
2. Mathioudakis NN, Everett E, Routh S, et al. Development and validation of a prediction model for insulin-associated hypoglycemia in non-critically ill hospitalized adults. BMJ Open Diabetes Res Care. 2018;6(1):e000499.
